药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Potassium cation
Naftidrofuryl
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Naftidrofuryl.
Potassium cation
Gallamine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Gallamine.
Potassium cation
Allobarbital
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Allobarbital.
Potassium cation
Emylcamate
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Emylcamate.
Potassium cation
Thiopropazate
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Thiopropazate.
Potassium cation
Moperone
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Moperone.
Potassium cation
Trifluperidol
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Trifluperidol.
Potassium cation
Bifemelane
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Bifemelane.
Potassium cation
Iprazochrome
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Iprazochrome.
Potassium cation
Gedocarnil
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Gedocarnil.
Potassium cation
Veralipride
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Veralipride.
Potassium cation
Mebicar
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Mebicar.
Potassium cation
Metergoline
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Metergoline.
Potassium cation
Emepronium
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Emepronium.
Potassium cation
Iprindole
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Iprindole.
Potassium cation
Meptazinol
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Meptazinol.
Potassium cation
Oxaflozane
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Oxaflozane.
Potassium cation
Phenibut
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Phenibut.
Potassium cation
Nicomorphine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Nicomorphine.
Potassium cation
Medazepam
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Medazepam.